Intuitive Surgical Files 8-K for Regulatory Disclosures

Ticker: ISRG · Form: 8-K · Filed: Mar 14, 2024 · CIK: 1035267

Sentiment: neutral

Topics: regulatory-filing, 8-K

Related Tickers: ISRG

TL;DR

ISRG filed a standard 8-K, no major news.

AI Summary

Intuitive Surgical, Inc. filed an 8-K on March 14, 2024, to report on Regulation FD disclosures and financial statements/exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements for the date.

Why It Matters

This filing indicates routine corporate reporting and does not signal any immediate material changes or new information for investors.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any new risks or material events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Intuitive Surgical, Inc.?

The primary purpose is to report on Regulation FD disclosures and to file financial statements and exhibits as of March 14, 2024.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported is March 14, 2024.

In which state is Intuitive Surgical, Inc. incorporated?

Intuitive Surgical, Inc. is incorporated in Delaware.

What is the address of Intuitive Surgical, Inc.'s principal executive offices?

The address of the principal executive offices is 1020 Kifer Road, Sunnyvale, California 94086.

Does this 8-K filing announce any new material events or financial results?

This filing primarily serves as a notification for Regulation FD disclosures and the filing of exhibits, and does not appear to announce specific new material events or financial results within the provided text.

Filing Stats: 575 words · 2 min read · ~2 pages · Grade level 8.7 · Accepted 2024-03-14 16:32:49

Key Financial Figures

Filing Documents

01

Item 7.01. Regulation FD Disclosure. On March 14, 2024, Intuitive Surgical, Inc. ("Intuitive") issued a press release announcing U.S. Food and Drug Administration clearance of its fifth-generation robotic system, da Vinci 5. A copy of the press release is furnished hereto as Exhibit 99.1. Intuitive will hold a teleconference at 5:45 a.m. PDT on Monday, March 18, 2024, to discuss the da Vinci 5 features and benefits and our launch plans. The call will be webcast and can be accessed on Intuitive's website at www.intuitive.com or by dialing (844) 291-6362 using the access code 5898411. The webcast replay of the call will be made available on our website at www.intuitive.com within 24 hours after the end of the live teleconference and will be accessible for at least 30 days. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing of Intuitive under the Securities Act of 1933, as amended, or the Exchange Act.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description. 99.1 Press release issued by Intuitive Surgical, Inc., dated March 14, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INTUITIVE SURGICAL, INC. Date: March 14, 2024 By: /S/ J AMIE E. S AMATH Name: Jamie E. Samath Title: Senior Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing